192 related articles for article (PubMed ID: 16123338)
1. Cardiac-specific overexpression of peroxisome proliferator-activated receptor-alpha causes insulin resistance in heart and liver.
Park SY; Cho YR; Finck BN; Kim HJ; Higashimori T; Hong EG; Lee MK; Danton C; Deshmukh S; Cline GW; Wu JJ; Bennett AM; Rothermel B; Kalinowski A; Russell KS; Kim YB; Kelly DP; Kim JK
Diabetes; 2005 Sep; 54(9):2514-24. PubMed ID: 16123338
[TBL] [Abstract][Full Text] [Related]
2. Rescue of cardiomyopathy in peroxisome proliferator-activated receptor-alpha transgenic mice by deletion of lipoprotein lipase identifies sources of cardiac lipids and peroxisome proliferator-activated receptor-alpha activators.
Duncan JG; Bharadwaj KG; Fong JL; Mitra R; Sambandam N; Courtois MR; Lavine KJ; Goldberg IJ; Kelly DP
Circulation; 2010 Jan; 121(3):426-35. PubMed ID: 20065164
[TBL] [Abstract][Full Text] [Related]
3. Astragalus polysaccharides repress myocardial lipotoxicity in a PPARalpha-dependent manner in vitro and in vivo in mice.
Chen W; Lai Y; Wang L; Xia Y; Chen W; Zhao X; Yu M; Li Y; Zhang Y; Ye H
J Diabetes Complications; 2015 Mar; 29(2):164-75. PubMed ID: 25499591
[TBL] [Abstract][Full Text] [Related]
4. Therapy with Astragalus polysaccharides rescues lipotoxic cardiomyopathy in MHC-PPARα mice.
Chen W; Chen W; Xia Y; Zhao X; Wang H; Yu M; Li Y; Ye H; Zhang Y
Mol Biol Rep; 2013 Mar; 40(3):2449-59. PubMed ID: 23196711
[TBL] [Abstract][Full Text] [Related]
5. Palmitoleic Acid Improves Metabolic Functions in Fatty Liver by PPARα-Dependent AMPK Activation.
de Souza CO; Teixeira AAS; Biondo LA; Lima Junior EA; Batatinha HAP; Rosa Neto JC
J Cell Physiol; 2017 Aug; 232(8):2168-2177. PubMed ID: 27925195
[TBL] [Abstract][Full Text] [Related]
6. Hormone-sensitive lipase knockout mice have increased hepatic insulin sensitivity and are protected from short-term diet-induced insulin resistance in skeletal muscle and heart.
Park SY; Kim HJ; Wang S; Higashimori T; Dong J; Kim YJ; Cline G; Li H; Prentki M; Shulman GI; Mitchell GA; Kim JK
Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E30-9. PubMed ID: 15701680
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice.
Ide T; Tsunoda M; Mochizuki T; Murakami K
Med Sci Monit; 2004 Oct; 10(10):BR388-95. PubMed ID: 15448592
[TBL] [Abstract][Full Text] [Related]
8. A Novel Function of Hepatic FOG2 in Insulin Sensitivity and Lipid Metabolism Through PPARα.
Guo Y; Yu J; Deng J; Liu B; Xiao Y; Li K; Xiao F; Yuan F; Liu Y; Chen S; Guo F
Diabetes; 2016 Aug; 65(8):2151-63. PubMed ID: 27207553
[TBL] [Abstract][Full Text] [Related]
9. A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes.
Finck BN; Bernal-Mizrachi C; Han DH; Coleman T; Sambandam N; LaRiviere LL; Holloszy JO; Semenkovich CF; Kelly DP
Cell Metab; 2005 Feb; 1(2):133-44. PubMed ID: 16054054
[TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues.
Wang H; Knaub LA; Jensen DR; Young Jung D; Hong EG; Ko HJ; Coates AM; Goldberg IJ; de la Houssaye BA; Janssen RC; McCurdy CE; Rahman SM; Soo Choi C; Shulman GI; Kim JK; Friedman JE; Eckel RH
Diabetes; 2009 Jan; 58(1):116-24. PubMed ID: 18952837
[TBL] [Abstract][Full Text] [Related]
11. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
Aasum E; Cooper M; Severson DL; Larsen TS
Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
[TBL] [Abstract][Full Text] [Related]
12. Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart.
Burkart EM; Sambandam N; Han X; Gross RW; Courtois M; Gierasch CM; Shoghi K; Welch MJ; Kelly DP
J Clin Invest; 2007 Dec; 117(12):3930-9. PubMed ID: 18037994
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.
Liu F; Song R; Feng Y; Guo J; Chen Y; Zhang Y; Chen T; Wang Y; Huang Y; Li CY; Cao C; Zhang Y; Hu X; Xiao RP
Circulation; 2015 Mar; 131(9):795-804. PubMed ID: 25637627
[TBL] [Abstract][Full Text] [Related]
14. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
15. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
[TBL] [Abstract][Full Text] [Related]
16. CD36 deficiency rescues lipotoxic cardiomyopathy.
Yang J; Sambandam N; Han X; Gross RW; Courtois M; Kovacs A; Febbraio M; Finck BN; Kelly DP
Circ Res; 2007 Apr; 100(8):1208-17. PubMed ID: 17363697
[TBL] [Abstract][Full Text] [Related]
17. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
19. Glucagon and lipid interactions in the regulation of hepatic AMPK signaling and expression of PPARalpha and FGF21 transcripts in vivo.
Berglund ED; Kang L; Lee-Young RS; Hasenour CM; Lustig DG; Lynes SE; Donahue EP; Swift LL; Charron MJ; Wasserman DH
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E607-14. PubMed ID: 20663988
[TBL] [Abstract][Full Text] [Related]
20. Soy β-conglycinin improves glucose uptake in skeletal muscle and ameliorates hepatic insulin resistance in Goto-Kakizaki rats.
Tachibana N; Yamashita Y; Nagata M; Wanezaki S; Ashida H; Horio F; Kohno M
Nutr Res; 2014 Feb; 34(2):160-7. PubMed ID: 24461318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
